| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 6 |
| 1 | ADALIMUMAB-AATY | 6 |
| 2 | ADALIMUMAB-ADAZ | 6 |
| 3 | ADALIMUMAB-FKJP | 6 |
| 4 | ASPIRIN | 3 |
| 5 | ASPIRIN 325 MG | 3 |
| 6 | ASPIRIN 81 MG | 3 |
| 7 | BEVACIZUMAB | 3 |
| 8 | CLONAZEPAM | 3 |
| 9 | ERGOCALCIFEROL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADALIMUMAB-AACF | 1 | 0.0030 |
| 1 | CEFPODOXIME PROXETIL | 1 | 0.0010 |
| 2 | TRANDOLAPRIL TABLETS | 1 | 0.0005 |
| 3 | NEOMYCIN SULFATE | 1 | 0.0004 |
| 4 | DEXMEDETOMIDINE HYDROCHLORIDE | 1 | 0.0003 |
| 5 | DESOGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0003 |
| 6 | HYDROXYZINE PAMOATE | 1 | 0.0003 |
| 7 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 8 | TEMSIROLIMUS | 1 | 0.0002 |
| 9 | BLEOMYCIN SULFATE | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 7 |
| 1 | Corticosteroid [EPC] | 6 |
| 2 | Kinase Inhibitor [EPC] | 6 |
| 3 | Benzodiazepine [EPC] | 5 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 5 |
| 5 | Proton Pump Inhibitor [EPC] | 5 |
| 6 | Platinum-based Drug [EPC] | 4 |
| 7 | Aromatase Inhibitor [EPC] | 3 |
| 8 | Estrogen [EPC] | 3 |
| 9 | Factor Xa Inhibitor [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 2 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |
| 3 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 5 | 0.0001 |
| 5 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 6 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 7 | Bile Acid [EPC] | 1 | 0.0000 |
| 8 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 9 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |